Navigation Links
Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Date:6/1/2008

pport. The maximum tolerated dose (MTD) was not reached in the study. These data indicate that the dose of (90)Yttrium used with the Zevalin regimen can be escalated provided there is a stem cell rescue.

(90)Yttrium Ibritumomab Tiuxetan Combined with High-dose BEAM Chemotherapy and Autologous Stem Cell Transplantation for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma, Abstract 8615

The goal of this phase II trial was to evaluate the safety and efficacy of combining RIT with high-dose carmustine, cytarabine, etoposide, and melphalan (BEAM) chemotherapy and ASCT in patients with relapsed or refractory NHL. With a median follow up of 11 months, results from the first ten patients showed adverse events were similar to those seen with high-dose BEAM alone. The authors concluded that these preliminary results suggest that the combination of RIT and BEAM followed by ASCT is does not add significantly to the toxicity of BEAM alone and the combination is effective therapy.

About Zevalin(R)

Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion- related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
4. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
5. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
6. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
7. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
11. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...- A new generation of ultrasmall transistors and m...called semiconducting nanowires are closer to real...urdue University and the University of California ...ow to create nanowires with layers of different ma...el, which is a critical requirement for making eff...
(Date:11/25/2009)...swire/--BiotechfirmReplikinsLtd.,whichhasanalyzedt...heprediction,outbreak,andprogressofthecurrentH1N1p...hevirus.ThenewdatashowsthatthelethalityoftheH1N1("...duringthevirus,scurrentoutbreakinthespringof2009to...eH1N1virus,infectivitycount,however,remainsincreas...
(Date:11/25/2009)...Fla.,Nov.25/PRNewswire/--Formanybusinesses,2009has...rgestandfastestgrowingnetworkofexpertphysiciansspe...icalhormones has grownthenumberof physiciansinit...-andisinprogresstoaddmorephysician-ownedcenters,in...nthepastyear ,BodyLogicMDhasopened13newbioidentica...
(Date:11/25/2009)...wswire-Asia/--SinovacBiotechLtd.(SVA),aleadingdev...ecuted,ajointventure(JV)agreementtoestablishSinova....TheJVwillresearch,develop,produce,andcommercializ...se,andexperienceindevelopingandcommercializingworl...ights,manufacturingfacilitiesand,establishedoperat...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...g to be highlighted, TSX Exchange Symbol: RVX, C...ix Corp.,("Resverlogix" or the "Company") (TSX:RVX...rug is featured prominently in an article titled,"... the current edition of,Expert Opinion of Emerging...e pharmaceutical industry. The article written by ...
...RNewswire-FirstCall/ --,China-Biotics, Inc. (OTC B...y"), a leading Chinese firm specializing in the ma...tribution of probiotics products,today announced i...lobal,Market ("Nasdaq")., "This is an important m...o working with Nasdaq to fulfill all of its listin...
... to see inside a magnet that,s smaller than the he...e invented a new kind of MRI technique to do just ...evelopment of extremely small computers, and even ...n blood vessels that play a role in diseases such ...l Review Letters, the scientists report the first...
Other Biology Technology:Resverlogix's Lead Drug Featured in Key Scientific Publication 2China-Biotics, Inc. Files Application for Nasdaq Listing 2New kind of MRI enables study of magnets for computer memory 2New kind of MRI enables study of magnets for computer memory 3
(Date:11/26/2009)... Ecologists have at last worked out a way of using...size of bird populations. This is the first time s...translated into accurate estimates of bird species... in the British Ecological Society,s Journal of A...t could lead to a major advance in our ability to ...
(Date:11/26/2009)... CAMBRIDGE, Mass. (November 26, 2009) Whitehead r...reen for human cells to pinpoint specific genes an...aper in Science . , In most human cell cultures...om the father and one from the mother. Gene inacti...e when one copy is inactivated, the second copy us...
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aureu...nnihilation as low-temperature plasma prototype de...sy and unfailing bactericidal cocktails. , Two p...cient disinfection of healthy skin (e.g. hands and...ia can pose a lethal threat; and another to shoot ...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 1Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 2Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 3Organic weed control for dandelions 9824 1Organic weed control for dandelions 9824 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2
...mbs to treating post trauma, the U.S. armed forces...ty of Houston will host a Department of Defense (D.... 1 and 2 at the Hilton UH Hotel and Conference Ce...e attendees an opportunity to connect with DoD ser...research expertise related to various aspects of d...
...t New Mexico State University recently discovered ...ariety of chile pepper originating in Assam, India...the worlds hottest chile pepper by blasting past t...ts of Scoville heat units (SHUs), Bhut Jolokia rea...ed Savina, which measured a mere 577,000. , Dr. P...
...d Technology (CAST) will make three presentations ...ual Meetings of the American Society of Agronomy (...Soil Science Society of America (SSSA). The presen...ntaries on biofuel byproducts and ethanol producti...r gathering, compiling, and communicating the late...
Other Biology News:US Army, US Navy, US Air Force, US Marines, US Department of Defense conference held at UH 2US Army, US Navy, US Air Force, US Marines, US Department of Defense conference held at UH 3CAST rolls out biofuel commentaries in New Orleans 2
...g Purification Kits enable rapid analytical to med...teins produced from appropriate vectors. Sufficien...1 mg target protein under native or denaturing con...n Agarose, which specifically retains STag fusion ...
Anti-S-100 protein, ab heterodimer Monoclonal Antibody, Unconjugated from HyTest Ltd.
Baker's yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
...ents (g/L):,Tryptone, 10 ,Yeast extract, 5 ,...erric ammonium citrate, 0.5 ,IPTG, 0.03 ,-Gal...genic substrate for -galactosidase. The enzymatic ...black insoluble precipitate. Lac+ colonies grown i...
Biology Products: